4.5 Article

Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum

Daiki Masukawa et al.

Summary: Dopamine (DA) is involved in neurological and physiological functions such as motor control. L-3,4-dihydroxyphenylalanine (L-DOPA), traditionally seen as an inert precursor of DA, is now shown to be a neurotransmitter itself.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Cell & Tissue Engineering

L-DOPA-Induced Neurogenesis in the Hippocampus Is Mediated through GPR143, a Distinct Mechanism of Dopamine

Yuka Kasahara et al.

Summary: Neurogenesis in the hippocampus is regulated by L-DOPA and its receptor GPR143 independently of dopamine. Low concentrations of L-DOPA promote neurogenesis, and its effect is abolished in GPR143 gene-deficient mice. Decreased neurogenesis and exacerbated depression-like behavior are observed in adult GPR143 gene-deficient mice, but can be attenuated by replenishment of GPR143 in the hippocampus.

STEM CELLS (2022)

Review Biochemistry & Molecular Biology

Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment

Milky Kohno et al.

Summary: This review compares the epidemiology of cocaine and methamphetamine use disorder, discusses the effects of drugs on the dopamine system, and summarizes treatment results from pharmacological clinical trials.

MOLECULAR PSYCHIATRY (2022)

Review Biochemistry & Molecular Biology

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease

Allen P. F. Chen et al.

Summary: Dopamine plays a crucial role in controlling CNS function and its dysregulation can lead to various cognitive symptoms associated with neuropsychiatric diseases. Different brain areas have varying functions and roles for dopamine, suggesting potential differential dysregulation in different disease states.

BIOMEDICINES (2021)

Review Pharmacology & Pharmacy

L-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease

Yoshio Goshima et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Medicine, Research & Experimental

L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor

Daiki Masukawa et al.

JCI INSIGHT (2017)

Article Biochemistry & Molecular Biology

L-DOPA is an endogenous ligand for OA1

Vanessa M. Lopez et al.

PLOS BIOLOGY (2008)